Clinical Trial and Sponsored Research Agreements (License Agreements) (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2022 |
Jun. 30, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
|
| Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] | ||||
| Research and development for licenses acquired | $ 1,000 | $ 0 | $ 1,000 | |
| Car T Technology [Member] | Mayo Clinic [Member] | ||||
| Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] | ||||
| Research and development for licenses acquired | $ 0 | $ 800 | $ 0 | $ 800 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The amount of the write-off for research and development assets that were acquired in a transaction other than a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|